Puma Biotechnology, Inc.
- Stock
- Ticker PBYI
- Nasdaq
Performance, volatility and drawdowns of Puma Biotechnology, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $1,610. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −98.8% in 05/2022, measured from the peak in 11/2017. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 59 | 46 | 52 | 54 | 75 | 45 | 57 | 55 |
| Gross profit | 45 | 35 | 40 | 42 | 52 | 34 | 44 | 40 |
| Operating income | 13 | 4.0 | 6.6 | 9.6 | 17 | -3.8 | 7.6 | 5.3 |
| EBITDA | 16 | 6.8 | 6.7 | 9.7 | 20 | -1.2 | 10 | 7.7 |
| Net income | 19 | 3.0 | 5.9 | 8.8 | 13 | -3.8 | 8.2 | 6.0 |
| Earnings per share | 0.40 | 0.06 | 0.12 | 0.17 | 0.26 | -0.07 | 0.16 | 0.11 |
| Balance sheet | ||||||||
| Total assets | 213 | 196 | 195 | 203 | 216 | 193 | 193 | 203 |
| Liabilities | 121 | 99 | 90 | 88 | 86 | 64 | 54 | 56 |
| Equity | 92 | 97 | 105 | 115 | 130 | 128 | 139 | 147 |
| Cash | 69 | 63 | 55 | 54 | 30 | 36 | 37 | 42 |
| Long-term debt | 22 | 11 | 11 | 0.0 | 0.0 | 0.0 | 0.0 | – |
| Cash flow | ||||||||
| Operating cash flow | 16 | 3.6 | 14 | 9.7 | 14 | 15 | 1.6 | 15 |
| Capital expenditure | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Free cash flow | 16 | 3.6 | 14 | 9.7 | 14 | 15 | 1.6 | 15 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2017 at +222.0%, weakest 2018 at −79.4%. 5 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 9 Nov 2026 | $0.11 |
| 6 Aug 2026 | $0.16 |
| 7 May 2026 | −$0.07 |
| 26 Feb 2026 | $0.26 |
| 6 Nov 2025 | $0.17 |
| 7 Aug 2025 | $0.12 |
| 8 May 2025 | $0.06 |
| 27 Feb 2025 | $0.40 |
| 7 Nov 2024 | $0.41 |
| 1 Aug 2024 | −$0.09 |
| 2 May 2024 | −$0.10 |
| 29 Feb 2024 | $0.25 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €330m
- Market cap in trading currency
- $364m
- Enterprise value
- $256m
- P/E
- 15.3
- P/S
- 1.57
- P/B
- 2.49
- EV/Sales
- 1.10
- EV/EBITDA
- 7.0
- Earnings yield
- 6.5%
- FCF yield
- 12.6%
Results (last four quarters)
- Revenue
- $232m
- Gross profit
- $171m
- EBITDA
- $36.3m
- Net income
- $23.8m
- Earnings per share
- $0.46
- Revenue per share
- $4.48
- Revenue growth
- +1.1%
- Earnings growth
- −32.7%
Profitability
- Gross margin
- 73.6%
- Operating margin
- 11.3%
- Net margin
- 10.3%
- Return on equity
- 18.2%
- Return on assets
- 11.8%
Balance sheet and cash flow
- Cash
- $109m
- Cash per share
- $2.10
- Financial debt
- $0
- Debt/equity %
- 0
- Current ratio
- 3.03
- Book value per share
- $2.84
- Operating cash flow
- $46.0m
- Free cash flow
- $46.1m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- 0%
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 51.7m
- Volume
- 861,208
- Avg. volume 3 months
- 366,692
- Relative volume
- 2.3
Price and technicals
- Price
- $7.05
- 1 day
- −1.0%
- 52-week high
- $11.26
- 52-week low
- $4.84
- Distance to 52-week high
- −37.4%
- Distance to 52-week low
- +45.7%
- Distance to 50-day line
- −26.1%
- Distance to 200-day line
- −12.3%
- RSI (14)
- 24
- Volatility 1M
- 69.1%
Performance
- 1 week
- −9.3%
- 1 month
- −37.4%
- 3 months
- −22.7%
- 6 months
- −0.4%
- YTD
- +18.5%
- 1 year
- +44.3%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has PBYI performed since 11/2016?
$10,000 grew to $1,610 by 20 Nov 2026, which is −16.7% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is PBYI?
Volatility was 80.5% per year, measured on monthly returns. The largest decline from a peak was −98.8%, with the low in 05/2022.
How does PBYI compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, PBYI returned −16.7% at 80.5%. The correlation of monthly returns was 0.29; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.